For women, our programs focus on balancing hormones, improving skin health, and managing weight gain
Additional Research Zheng et al
However, one limitation is that while we are utilizing STEP 1 eligibility criteria to identify the eligible NHANES participants, there may be differences between our participants and the STEP 1 clinical trial participants, and therefore the weight loss and cardiovascular risk factor changes observed in STEP 1 may not be entirely translatable to our NHANES sample
Obesity is a question of class, and the rise of these drugs which will soon be available to everyone for a few hundred euros a week only underscores that fact
Brand-name tirzepatide products typically cost $1,000 to $1,100 per month without insurance, slightly higher than brand-name semaglutide
You are seeing real results